Skip to content

908 Devices MASS EBITDA margin

EBITDA margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
24.2%-0.2pp
WAT
Waters CorporationWAT
18.7%-12.5pp
Agilent Technologies logo
Agilent TechnologiesA
25.3%-0.2pp
Bruker logo
BrukerBRKR
7.9%-4.2pp
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
28.8%-1.0pp
Danaher logo
DanaherDHR
29.2%-0.9pp

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Calculated from 908 Devices’s reported figures.

Based on trailing twelve months.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's EBITDA margin?
908 Devices (MASS) reported EBITDA margin of -69.3% in Q1 2026.
How has 908 Devices's EBITDA margin changed year-over-year?
908 Devices's EBITDA margin increased by 35.7% year-over-year, from -107.8% to -69.3%.
What is the long-term trend for 908 Devices's EBITDA margin?
Over 5 years (2020 to 2025), 908 Devices's EBITDA margin has grown at a 29.6% compound annual growth rate (CAGR), from -18.5% to -67.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.